Adam R Craig
CIK 1339498 · Executive Chairman · last filed 2025-10-31
Adam R Craig is an Executive Chairman who has filed 31 SEC Form 4 insider transactions across 3 companies since 2012. The most recent filing, for XFOR, was dated Oct 31, 2025. Across all open-market trades the lifetime net is −$4.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.50M
3
31
-$4.83M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XFOR | Executive Chairman | 376,087 | $4.00 | $1.50M | $250.0K | 3 | 2025-10-31 |
| CTI BIOPHARMA CORP (CTIC) Delisted | President and CEO | 0 | $9.09 | $0 | -$5.06M | 19 | 2023-06-26 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | EVP, Development & CMO | 31,754 | $18.62 | $591.3K | -$20.4K | 6 | 2015-03-02 |
Recent Filings
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-31 | XFOR | Grant (A) | — | $0 | EDGAR |
| 2025-10-27 | XFOR | Buy (P) | +86,206 | $250.0K | EDGAR |
| 2025-08-14 | XFOR | Grant (A) | +289,881 | $0 | EDGAR |
| 2023-06-26 | CTI BIOPHARMA CORP (CTIC) Delisted | Mixed | −31,470 | -$286.4K | EDGAR |
| 2023-03-16 | CTI BIOPHARMA CORP (CTIC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-26 | CTI BIOPHARMA CORP (CTIC) Delisted | Mixed | — | -$440.2K | EDGAR |
| 2023-01-03 | CTI BIOPHARMA CORP (CTIC) Delisted | Mixed | +1,579 | -$589.4K | EDGAR |
| 2022-11-14 | CTI BIOPHARMA CORP (CTIC) Delisted | Mixed | — | -$1.25M | EDGAR |
| 2022-09-14 | CTI BIOPHARMA CORP (CTIC) Delisted | Mixed | — | -$1.35M | EDGAR |
| 2022-08-16 | CTI BIOPHARMA CORP (CTIC) Delisted | Buy (P) | +5,000 | $27.5K | EDGAR |